Zavesca 66215-0201

Generic: Miglustat

Product NDC

66215-0201

Manufacturer: Actelion Pharmaceuticals Us, Inc.
Dosage Form: Capsule
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: July 31, 2003
Listing Expires: December 31, 2026
Application: NDA021348

Need to source Zavesca? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Miglustat	100 mg/1

Drug Class

Glucosylceramide Synthase Inhibitor [EPC]Enzyme Stabilizer [EPC]Glucosylceramide Synthase Inhibitor [EPC]

Packaging Options(1)

66215-0201-90

6 BLISTER PACK in 1 CARTON (66215-201-90) / 15 CAPSULE in 1 BLISTER PACK (66215-201-15)

View →